304
Participants
Start Date
November 18, 2019
Primary Completion Date
August 18, 2023
Study Completion Date
August 18, 2023
Mexidol
50 mg/ml IV solution, 250 mg tablets
Placebo
Placebo IV solution, Placebo tablets
The first clinic of the Tashkent Medical Academy, Tashkent
Federal Center for Brain and Neurotechnology, Moscow
Russian National Research Medical University n.a. N. I. Pirogov, Moscow
Yaroslavl Clinical Hospital № 2, Yaroslavl
Vsevolozhsk Clinical Interdistrict Hospital, Vsevolozhsk
Alexandrovskaya Hospital, Saint Petersburg
St. Petersburg Clinical Hospital № 26, Saint Petersburg
National Medical Research Center n.a. V. A. Almazov, Saint Petersburg
City Hospital № 40 of Kurortny District, Saint Petersburg
Rostov State Medical University, Rostov-on-Don
Research Institute - Regional Clinical Hospital № 1, Krasnodar
Voronezh Regional Clinical Hospital № 1, Voronezh
Tatarstan Republican Clinical Hospital, Kazan'
Interregional Clinical Diagnostic Center, Kazan'
Kazan City Hospital № 7, Kazan'
Central Clinical Medical and Sanitary Unit n.a. V. A. Egorov, Ulyanovsk
Samara Regional Clinical Hospital n.a. V. D. Seredavin, Samara
Kemerovo City Clinical Hospital № 11, Kemerovo
Almaty City Hospital № 7, Almaty
Lead Sponsor
Pharmasoft
INDUSTRY